For decades, the paradigm of developing small molecule drugs was the mandate of all pharmaceutical companies. Peptide products were considered too unstable to be utilized as drugs even though our bodies produce them for tightly controlling many of our physiological processes.
With improvements to GMP manufacturing methods coupled with those in formulation and delivery, peptides are now readily being developed in both industrial and academic settings as drug candidates.
AmbioPharm is uniquely positioned to partner from the earliest stages of peptide development all the way through commercial production under full GMP in a very economical manner.
Please contact us to learn how we can help you on your peptide journey.